Key result
Gabapentinoid use trends among the US adult population between 2002 and 2015 were characterized using Medical Expenditure Panel Survey data.
This study characterizes the trends in gabapentinoid use among US adults between 2002 and 2015.
Informs national prescribing surveillance; leaves open associations with outcomes and appropriateness of use.
This cohort study uses 2002-2015 Medical Expenditure Panel Survey data to characterize the use of gabapentinoids among the US adult population.
No takes yet. Share an insight, caveat, or question.
Michael E. Johansen (2018) studied this question. Gabapentinoid use trends among the US adult population between 2002 and 2015 were characterized using Medical Expenditure Panel Survey data.